In Vivo production and delivery of erythropoietin or insulinotropin for gene therapy
The invention provides primary and secondary cells that are transfected
with a nucleic acid molecule that encodes erythropoietin, clonal or
heterogenous strains of such cells, and methods of producing these cell
strains.